The outcomes demonstrated that high STAT3/p-STAT3 expression in ovarian cancer tissue was correlated with a higher FIGO stage, a more advanced tumour grade, a higher risk of lymph node metastasis, non-mucinous ovarian cancer, shorter overall survival, and shorter progression-free survival. The gene discussed is STAT3; the disease is mucinous ovarian cancer.